Insights on Life Sciences


Embedding ‘smart quality’ culture and capabilities in the organization

– Pharmaceutical and medical-device companies can get the most value from “smart quality” processes enabled with new technologies by adopting a holistic approach to building culture and capabilities.

From extreme to mainstream: The future of aesthetics injectables

– McKinsey research shows that the global aesthetics injectables market could grow by 12 to 14 percent a year over the next five... years if manufacturers and providers capitalize on the underlying trends.

The UK biotech sector: The path to global leadership

– The United Kingdom is Europe’s leading biotech hub in breakthrough life-sciences start-ups. How is this hub maturing relative... to its global peers, and what lies ahead on the road to sustainable scale?

A new operating model for pharma: How the pandemic has influenced priorities

– The COVID-19 pandemic has prompted pharma companies to rethink their organizational strategies. A survey of executives suggests... where value might lie.

The race to create a vaccine: A conversation with Frank D’Amelio

– The CFO of Pfizer talks about what it took to develop a COVID-19 vaccine.

Integrated evidence generation: A paradigm shift in biopharma

– Biopharma companies should consider a new, integrated approach to evidence-generation strategies to better demonstrate the value... of therapies to all stakeholders.
Podcast - McKinsey Global Institute

Forward Thinking on the enduring power of engineering in a digitizing world with Hayaatun Sillem

– The first female CEO of the United Kingdom’s Royal Academy of Engineering reflects on the evolving role of engineering in... a dematerializing world, its vital role in science and sustainability—and collaborating with a Formula One world champion.

The dawn of China biopharma innovation

– Chinese biopharma is making a mark on the global stage as the rapidly evolving regulatory landscape and maturing innovation ecosystem... spur significant value creation.

The case for cloud in life sciences

– As cloud technology matures, life-sciences companies are generating new paths to business value beyond the cost efficiencies that... cloud migrations typically target.

Special collection

Future of pharma operations

Pharma companies are experiencing a wave of innovations – from new treatment modalities, to smart machines, advanced analytics, and digital connectivity. This selection of articles presents strategies and insights to capitalize on these innovations and advance quality, efficiency, resilience, and workforce agility in pharma operations. Contact us to learn more.

Coronavirus vaccines progress: What’s next?

The rapid development of the COVID-19 vaccines is having a profound effect on the world. This collection takes a closer look at the development, rollout and future of vaccines.

McKinsey insights on cell and gene therapy

Continuing advances in cell and gene therapy (CGT) are transforming how biopharma companies treat and potentially cure certain diseases. Browse our collection of articles for an in-depth look at the opportunities, challenges, and implications for stakeholders in this fast-evolving field, and explore how McKinsey’s new Digital Capability Center for Cell and Gene Therapy will help biopharma companies accelerate digital transformations in manufacturing and the journey to operational excellence. Contact us to learn more.

The rise of health technology

Health technology continues to push the boundaries of how healthcare is delivered and has the power to create breakthroughs in our understanding of disease. This collection of articles and interviews explores the evolving role of health technology in the life-sciences sector and implications for key stakeholders. Contact us to learn more about our work in this field.

Want to learn more about how we help clients in Life Sciences?

More insights

Executive Briefing

COVID-19: Implications for business

– Our latest perspectives on the coronavirus outbreak, the twin threats to lives and livelihoods, and how organizations can prepare... for the next normal.
Executive Briefing

COVID-19: Implications for business

– Our latest perspectives on the coronavirus outbreak, the twin threats to lives and livelihoods, and how organizations can prepare... for the next normal.

How medtech companies can create value with new-business building

– Medtech industry senior executives recently convened to discuss new-business building. Their experiences illuminate what it can... do for companies, why it’s so difficult, and how to get it right.

Clinical supply chains: How to boost excellence and innovation

– Clinical trials have increased in number and have become more complex, decentralized, and patient-centric. While this puts pressure... on clinical drug supply, it also brings new opportunities.

Accelerating pandemic response efforts: An interview with CEPI’s Richard Hatchett

– Amid the COVID-19 crisis, the CEO of the Coalition for Epidemic Preparedness Innovations explains his five-year strategy that... includes reducing vaccine timelines.

The rise of digital marketing in medtech

– Digital marketing offers medtech companies powerful ways to personalize engagement with healthcare professionals and respond to... their changing needs.

Four ways pharma companies can make their supply chains more resilient

– Pharmaceutical supply chains have become global and complex. With more outsourcing, new modalities, and novel ways to reach patients,... it’s critical to ensure that they can withstand shocks.

Pfizer’s mix of science and grit alters the course of its COVID-19 response

– Angela Hwang, Pfizer’s head of biopharmaceuticals, talks about breaking new ground when the pressure is on—and how... having a deep company heritage can help.

Port to patient: Improving country cold chains for COVID-19 vaccines

– In many developing countries, limitations of existing cold chains will provide challenges for COVID-19-vaccine distribution. Strategic... distribution planning and targeted investment can help.

Infographic: Biotech in Europe: Driving the next act

– How can biotechs and investors succeed in the future? To scale up innovation, industry stakeholders need to focus on several key... areas.

Infographic: Capital landscape for European biotechs is maturing, but it continues to trail the United States

– Europe’s biotech sector has made meaningful progress in attracting capital. However, raising more capital will be essential... to the continued growth of this sector.
Sorry, we couldn't find any results. Try removing some filters.

Connect with our Life Sciences Practice